CVKD · Cadrenal Therapeutics Inc
United States · RS rating 18 · As of 2026-11-03
| Price | 1.13 USD |
|---|---|
| 1-day change | +8.7% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 93 / 12 / 4 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 7 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -9.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +91.6% |
| Market cap (USD) | $13.9M |